Yifan Pharmaceutical Co Ltd
SZSE:002019
Yifan Pharmaceutical Co Ltd
Tax Provision
Yifan Pharmaceutical Co Ltd
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Y
|
Yifan Pharmaceutical Co Ltd
SZSE:002019
|
Tax Provision
-¥56.7m
|
CAGR 3-Years
21%
|
CAGR 5-Years
18%
|
CAGR 10-Years
-1%
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Tax Provision
-¥1.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-20%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Tax Provision
-¥488.7m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Tax Provision
-¥546.1m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-22%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Tax Provision
-¥433m
|
CAGR 3-Years
10%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-8%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Tax Provision
-¥704.7m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-6%
|
See Also
What is Yifan Pharmaceutical Co Ltd's Tax Provision?
Tax Provision
-56.7m
CNY
Based on the financial report for Mar 31, 2024, Yifan Pharmaceutical Co Ltd's Tax Provision amounts to -56.7m CNY.
What is Yifan Pharmaceutical Co Ltd's Tax Provision growth rate?
Tax Provision CAGR 10Y
-1%
The average annual Tax Provision growth rates for Yifan Pharmaceutical Co Ltd have been 21% over the past three years , 18% over the past five years , and -1% over the past ten years .